期刊
FEBS LETTERS
卷 590, 期 15, 页码 2482-2493出版社
WILEY
DOI: 10.1002/1873-3468.12285
关键词
cardiac disease modelling; induced pluripotent stem cell-derived cardiomyocytes; molecular mechanisms
资金
- European Research Council [ERCAdG 323182 STEMCARDIOVASC]
Induced pluripotent stem cells (iPSCs) were first generated 10 years ago. Their ability to differentiate into any somatic cell type of the body including cardiomyocytes has already made them a valuable resource for modelling cardiac disease and drug screening. Initially human iPSCs were used mostly to model known disease phenotypes; more recently, and despite a number of recognised shortcomings, they have proven valuable in providing fundamental insights into the mechanisms of inherited heart disease with unknown genetic cause using surprisingly small cohorts. In this review, we summarise the progress made with human iPSCs as cardiac disease models with special focus on the latest mechanistic insights and related challenges. Furthermore, we suggest emerging solutions that will likely move the field forward.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据